Use of Heliox in the Management of Neonates With Meconium Aspiration Syndrome
Study Details
Study Description
Brief Summary
The aim of the study: to assess the effect of short-term mechanical ventilation with heliox in newborns with meconium aspiration syndrome on vital signs, oxygenation, acid-base balance and respiratory function parameters.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Heliox
|
Other: Heliox mechanical ventilation
Mechanical ventilation (MV) with air-oxygen at baseline, then 1 hour of heliox (helium-oxygen) MV and then return to MV with air-oxygen.
|
Outcome Measures
Primary Outcome Measures
- Changes in acid-base balance and oxygenation [Parameters recorded first at the baseline during ventilation with air-oxygen gas mixture, then after 15 and 60 minutes of the heliox ventilation and finally 15 and 60 minutes after switching back to air-oxygen ventilation.]
Acid-base balance and oxygenation assessed on arterial blood gas samples, saturation measured with a pulse oximeter and calculated values of oxygenation index and alveolar-arterial oxygen tension difference.
Secondary Outcome Measures
- Changes in respiratory parameters [Parameters recorded first at baseline during ventilation with air-oxygen gas mixture, then after 15 and 60 minutes of the heliox ventilation and finally 15 and 60 minutes after switching back to air-oxygen ventilation.]
Analyzed parameters: tidal volume (VT, [ml/kg]), minute ventilation (VE, [l]) and peak expiratory flow rate (PEFR, [l/min]). Recorded ventilator settings: respiratory rate (RR), mean airway pressure (MAP) and fraction of inspired oxygen (FiO2).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
meconium aspiration syndrome diagnosed based on clinical and radiological findings,
-
respiratory failure requiring mechanical ventilation
Exclusion Criteria:
-
congenital malformations or congenital genetic syndromes,
-
persistent pulmonary hypertension of the newborn (PPHN) requiring inhaled nitric oxide treatment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Neonatology at Poznań University of Medical Sciences | Poznań | Poland | 60-535 |
Sponsors and Collaborators
- Poznan University of Medical Sciences
Investigators
- Principal Investigator: Tomasz Szczapa, MD, PhD, Department of Neonatology at Poznań University of Medical Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 503-02-02215338-22961-03550